http://pkforum.com/vb/ en Wed, 08 Sep 2010 07:29:23 GMT vBulletin 60 http://www.pkforum.com/vb/images/IPB/misc/rss.png http://pkforum.com/vb/ http://pkforum.com/vb/threads/11857-CAMERAS-Brand-New-Nikon-D700-700-USD?goto=newpost Thu, 02 Sep 2010 17:38:55 GMT *We are Distributor of Mobile phones and Video Games, We specialize in competitively-priced original and high-quality. We are the Given our... We are Distributor of Mobile phones and Video Games, We specialize in
competitively-priced original and high-quality. We are the Given our
products at a discounted prices.

COMPANY NAME;LAVA TECHNOLOGIES LIMITED
Registered No. 03891045
BOUNDARY HOUSE, 91-93 CHARTERHOUSE STREET, LONDON, EC1M 6HR, EC1M 6HR
Sales Manager:Mr Smith

Products Price:
Apple iphone 3gs 32gb--$300
Apple iPhone 4GB-------$150
Apple iPhone 8GB-------$180
Apple iphone 3G 16GB---$180

Sidekick LX -- $120
Sidekick 3 --- $115
Juicy Couture Sidekick 2 -- $100
Mister Cartoon Sidekick -- $110
Juicy couture Sidekick III--$110
Sidekick D - Wade --- $110
Sidekick ID----- $100

HTC P6500 Sirius Pocket PC--$250
T-Mobile G1 Android HTC--$220
HTC Touch HD--$220
HTC Touch Diamond P3700 --$220
HTC Touch PRO EU----$220
HTC Advantage X7500---$220
HTC P4550 TYTN II Pocket PC--$150
At&t Tilt 8925 Pocket PC--$140
HTC Touch Dual P5500--$140
HTC Touch Dual NA P5520--$140
HTC Touch Cruise P3650 Polaris 3G--$160
HTC TYTN Pocket PC----$130
HTC Touch Smartphone--$130
HTC P3470 Smartphone--$130

Eten glofiish M750 -- $250
Eten glofiish M810 -- $225
Eten glofiish X650 -- $200
Eten glofiish M800 -- $215
Eten glofiish X600 -- $190
Eten glofiish X500+ -- $170
Eten glofiish X800 -- $215
Eten glofiish M700 -- $180
Eten glofiish X500 -- $160
Eten M550 -- $110
Eten G500 -- $115
Eten M600 -- $120

Nokia 5610 XpressMusic Red--$120
Nokia 6500 Classic Black---$120
Nokia N81 8GB---$140
Nokia 8800 Arte---$350
Nokia N95-3------$170
Nokia 8600 US Luna---$250
Nokia N95-2 8GB--$200
Nokia N96 16GB--$230
Nokia E90 Communicator----$200
Nokia N78 Blue---$180
Nokia E71-3 EU--$170
Nokia E66---$140
Nokia E71-2 NA--$170
Nokia 6500--$100
Nokia 3600--$100
Nokia 6600--$120
Nokia N77--$200
Nokia E61i--$110
Nokia N800--$120

BlackBerry Storm 9530--$250
BlackBerry Storm 9500--$250
BlackBerry Bold 9000 -- $200
BlackBerry Pearl 8110 -- $150
BlackBerry Pearl 8120 -- $150
BlackBerry Curve 8320 -- $170
BlackBerry Curve 8310 -- $155
BlackBerry Curve 8300 -- $160
BlackBerry 8820 -- $135
BlackBerry 8830-- $170
BlackBerry 8800 -- $145
BlackBerry Pearl 8100 -- $120

Sony Ericsson C905--$220
Sony Ericsson XPERIA X1--$250
Sony Ericsson G502--$150
Sony Ericsson T303--$120
Sony Ericsson G900--$180
Sony Ericsson W980--$150
Sony Ericsson C902--$120
Sony Ericsson Z770--$120
Sony Ericsson W760--$130
Sony Ericsson W890--$135
Sony Ericsson K660--$100
Sony Ericsson K770--$115
Sony Ericsson K850--$120
Sony Ericsson W960--$160
Sony Ericsson W910--$140
Sony Ericsson P1 -- $120

Samsung Omnia 16GB-----$250
Samsung Omnia 8GB------$200
Samsung Instinct sprint----$200
Samsung G800 -- $160
Samsung U900 Soul -- $185
Samsung F490 -- $175
Samsung Giorgio Armani P520-- $160
Samsung F480 -- $190
Samsung F110 -- $135

Motorola ZN200---$200
Motorola Aura--$200
Motorola RAZR2 V9 -- $170
Motorola RIZR Z10 -- $180
Motorola ROKR E8 -- $110
Motorola U9 -- $100
Motorola Z9 -- $100
Motorola Z6w -- $120
Motorola Z6c -- $110
Motorola RIZR Z8 -- $170
Motorola KRZR K3 -- $110
Motorola SLVR L9 -- $100
Motorola Q 9h -- 185
Motorola Q 8 -- $140

Nikon cameras products all are brand new..
-----------------------------------------------------------------
CAMERAS Brand New Nikon D700 : $700 USD
CAMERAS Brand New Nikon D800 : $800 USD
CAMERAS Brand New Nikon D1000 : $1200 USD
Brand New Nikon D40 : $320USD
Brand New Nikon D40x : $350 USD
Brand New Nikon D60 ; $400 USD
Brand New Nikon D80 : $500 USD
Brand New Nikon D200 : $550 USD
Brand New Nikon D300 : $600 USD

VERTU PRICE LIST
Vertu Signature Standard Platinum-----$400
Vertu Signature Duo Stainless Steel---$350
Vertu Signature Standard White Gold---$450
Vertu Signature Standard Yellow Gold--$450
Vertu Ascent Pink-Special Editionfiltered--$400

GARMIN 396--$130
Playstation 3 40GB---$120
Playstation 3 60GB---$130
Playstation 3 80GB---$175
Playstation 3 80GB---$180
Sony PSP Value Pack--$85
GameBoy Advance------$70

Apple ipod itouch 32GB----$150
Apple ipod itouch 16GB----$120
Apple ipod itouch 8GB-----$100
Apple iPod 30GB (Video)---$100
Apple iPod 60GB (Video)---$100
Apple iPod Mini 6 GB------$100
Apple iPod Photo 30 GB----$110
Apple iPod U2 SE 20 GB----$120
Apple iPod Photo 60 GB----$120
Apple iPod 20 GB----------$100
Apple ipod 80 GB----------$120

Nintendo DS---$50
Nintendo Wii--$150

Xbox 360 Core System-----$160
Xbox 360 Prenium pack--$170
Xbox 360 Platinum Bundle Console-- $155
Xbox 360 Elite--------$$180
=======================================
APPLE LAPTOP:

Apple MacBook Pro (MA611LL/A) Notebook--$550
Apple MacBook (MA254LL/A) Mac Notebook--$400
Apple iBook G3 (M7698LL/A) Mac Notebook-$550
Apple MacBook Pro (MA609LL/A) Notebook--$500
Apple MacBook Pro (MA600LLA) Notebook---$450
Apple MacBook Pro (MA610LL/A) Notebook--$550
Apple Macbook Pro(885909119400)Notebook-$550
=======================================
SONY VAIO P4 LAPTOP:
Sony VAIO(R) PCG-GRT100 (PCG-GRT10012) PC Notebook----$400
Sony VAIO(R) PCG-GRT100P (PCG-GRT100P3 PC Notebook----$450
Sony VAIO(R) PCG-GRT100P (PCG-GRT100P56) PC Notebook--$500
Sony VAIO(R) PCG-GRT100P (PCG-GRT100P44) PC Notebook--$440
Sony VAIO(R) PCG-GRT100P (PCG-GRT100P17) PC Notebook--$300
Sony VAIO(R) PCG-V505BCP (PCG-V505BCP11) PC Notebook--$450
Sony VAIO(R) PCG-GRT100K (PCG-GRT100K23) PC Notebook--$440
=======================================
DELL LAPTOP:
Dell XPS M1710 PC Notebook--$300
Dell XPS M2010 PC Notebook--$500

All products are 100% tested and all brands new and all in perfect
working conditions. We send out products via reputable courier
companies and delivery is at your doorstep 2 days after shipment
(maximum)

Return Policy

All products must be returned within 15 days. In order to process your
return or exchange, please explain in detail why you need to return or
exchange your order. We will respond to you with RMA # (return
merchandise authorization) within 24-48hrs. DO NOT SHIP YOUR ORDER
WITHOUT RMA#. We will be responsible for the return shipping cost. We
strive to offer high-quality products at competitive prices.
We are committed to doing all it takes to satisfied all our customers!
Many thanks and God bless you as you place your order with us today.
For purchasing process. Kindly send your inquiries to:

EMAIL: ray_smithstore@yahoo.com
Regards
Sales Manager.Mr Smith
]]> Current Affairs xbox360 http://pkforum.com/vb/threads/11857-CAMERAS-Brand-New-Nikon-D700-700-USD http://pkforum.com/vb/threads/11849-پاکستان-کا-سیلاب-اورامریکہ-کی-امداد?goto=newpost Wed, 01 Sep 2010 15:08:15 GMT Ban me......................!!! Ban me......................!!! ]]> Current Affairs US CENTCOM http://pkforum.com/vb/threads/11763-NDM-1-New-superbug-found-in-UK-hospitals?goto=newpost Sat, 14 Aug 2010 07:12:17 GMT A new superbug that is resistant to even the most powerful antibiotics has entered UK hospitals, experts warn. They say bacteria that make an... A new superbug that is resistant to even the most powerful antibiotics has entered UK hospitals, experts warn.

They say bacteria that make an enzyme called NDM-1 have travelled back with NHS patients who went abroad to countries like India and Pakistan for treatments such as cosmetic surgery.

Although there have only been about 50 cases identified in the UK so far, scientists fear it will go global.

Tight surveillance and new drugs are needed says Lancet Infectious Diseases.

The fear would be that it gets into a strain of bacteria that is very good at being transmitted between patients”

NDM-1 can exist inside different bacteria, like E.coli, and it makes them resistant to one of the most powerful groups of antibiotics - carbapenems.

These are generally reserved for use in emergencies and to combat hard-to-treat infections caused by other multi-resistant bacteria.

And experts fear NDM-1 could now jump to other strains of bacteria that are already resistant to many other antibiotics.

Ultimately, this could produce dangerous infections that would spread rapidly from person to person and be almost impossible to treat.

At least one of the NDM-1 infections the researchers analysed was resistant to all known antibiotics.

Similar infections have been seen in the US, Canada, Australia and the Netherlands and international researchers say that NDM-1 could become a major global health problem.

Infections have already been passed from patient to patient in UK hospitals.



The way to stop NDM-1, say researchers, is to rapidly identify and isolate any hospital patients who are infected.

Normal infection control measures, such as disinfecting hospital equipment and doctors and nurses washing their hands with antibacterial soap, can stop the spread.

And currently, most of the bacteria carrying NDM-1 have been treatable using a combination of different antibiotics.

But the potential of NDM-1 to become endemic worldwide is "clear and frightening", say the researchers in The Lancet infectious diseases paper.

The research was carried out by experts at Cardiff University, the Health Protection Agency and international colleagues.

Dr David Livermore, one of the researchers and who works for the UK's Health Protection Agency (HPA), said: "There have been a number of small clusters within the UK, but far and away the greater number of cases appear to be associated with travel and hospital treatment in the Indian subcontinent.

"This type of resistance has become quite widespread there.

"The fear would be that it gets into a strain of bacteria that is very good at being transmitted between patients."

He said the threat was a serious global public health problem as there are few suitable new antibiotics in development and none that are effective against NDM-1.

The Department of Health has already put out an alert on the issue, he said.

"We issue these alerts very sparingly when we see new and disturbing resistance."
Travel history

The National Resistance Alert came in 2009 after the HPA noted an increasing number of cases - some fatal - emerging in the UK.

The Lancet study looked back at some of the NDM-1 cases referred to the HPA up to 2009 from hospitals scattered across the UK.

At least 17 of the 37 patients they studied had a history of travelling to India or Pakistan within the past year, and 14 of them had been admitted to a hospital in these countries - many for cosmetic surgery.

For some of the patients the infection was mild, while others were seriously ill, and some with blood poisoning.

A Department of Health spokeswoman said: "We are working with the HPA on this issue.

"Hospitals need to ensure they continue to provide good infection control to prevent any spread, consider whether patients have recently been treated abroad and send samples to HPA for testing.

"So far there has only been a small number of cases in UK hospital patients. The HPA is continuing to monitor the situation and we are investigating ways of encouraging the development of new antibiotics with our European colleagues."

The Welsh Assembly Government said it would be "fully considering" the report.

"The NHS in Wales is used to dealing with multi-resistant bacteria using standard microbiological approaches, and would deal with any new bacteria in a similar way," said a spokesperson.


----------------------


New Superbug Spurs Warning

LONDON—Governments will need to "pay up" and support drug discovery if big drug companies are to develop a new generation of antibiotics to fight deadly new infections, health experts say.

Researchers in an article published in the U.K. journal Lancet Wednesday identified a superbug that is resistant to most antibiotics and warned that it is widespread in India and could spread globally.

The new gene, called NDM-1, alters bacteria, allowing them to become resistant to nearly all known antibiotics including carbapenems, a group of antibiotics often reserved as a last resort for emergency treatment for multi-drug resistant bugs.

The NDM-1 gene was found on DNA structures, called plasmids, that can be easily copied and transferred between bacteria, giving the bug "an alarming potential to spread and diversify," the authors said.

Also worrying is the lack of drugs available to fight the threat. That situation is unlikely to change soon because of Big Pharma's relative lack of interest in the area, due to several factors.

"The most important ones are the fast development of resistances against many drugs, which shortens product lifespans for new antibiotics, as well as the high level of genericization throughout the antibacterials segment, which further reduces the commercial opportunity for new drugs," said Hediwg Kresse, lead infectious disease analyst at Datamonitor in London. "As a consequence, there is an overall lack of new antibiotics in development pipelines."

Another barrier is lack of clarify in R&D demands from official regulators.

Nonetheless, some large drug makers are actively investing in antibiotic research, such as U.S.-based Pfizer Inc. and Merck & Co., Switzerland's Novartis AG, and GlaxoSmithKline PLC and AstraZeneca PLC of the U.K.

"We believe there is great value in investing in medicines to treat this serious area of disease," said Anders Ekblom, AstraZeneca's executive vice president of global medicines development. "Bacteria are continually developing resistance to our arsenal of antibiotics, and NDM1 is just the latest example," he added.

In a statement Wednesday, GlaxoSmithKline said: "New antibiotics that work in different ways to existing medicines are desperately needed to tackle the rising incidence of antibiotics resistance."

Still, the area is a niche market for these participants given the limited prospects for return.

Experts say governments and drug and health-care regulators need to act if they are to help spur more investment in this type of research.

That is a message drug makers don't make publicly but press quietly, behind the scenes with decision makers. Analysts say the main issue is return on investment.

"Many prospective industry developers also see the regulatory environment more restrictive for antibiotics than for other therapeutic areas," said Chantal Morel, health economist at the London School of Economics.

"If companies could be assured a higher price for an effective new antibiotic we would probably not need any further incentives. Short of that, incentives that appear more promising than others are those that provide some early research subsidy—to level the playing field amongst small and large developers—as well as a strong financial lure once the product is fully developed."

Other incentives might include special designation similar to that currently giving orphan drugs major tax incentives, along with increased market exclusivity.

Write to Sten Stovall at sten.stovall@dowjones.com ]]> Current Affairs Asad http://pkforum.com/vb/threads/11763-NDM-1-New-superbug-found-in-UK-hospitals http://pkforum.com/vb/threads/11761-Economic-collapse?goto=newpost Sat, 14 Aug 2010 01:46:41 GMT Source: Dawn.com What could be worse than floods that have displaced millions, killed thousands and destroyed huge swathes of farmland, a... Source: Dawn.com

What could be worse than floods that have displaced millions, killed thousands and destroyed huge swathes of farmland, a catastrophe the country will take years to recover from?

Some people think they know, and the answer terrifies them. Away from the political mishegoss in Islamabad, calculators are anxiously being pulled out and back-of-the-envelope calculations are furiously being made by the serious-minded folks.

The numbers are numbing: even before the floods, Pakistan seemed to be heading for economic collapse; after the floods, that appears to be all but a certainty.

Gone will be the days of loadshedding — because there will be no electricity at all in the grid. Inflation, which has stayed stubbornly high, will spike again — because a sustained budget deficit is forcing the government to borrow money, keeping the economy awash in surplus money, more cash chasing the same amount of goods.

Revenue projections could collapse — because piling on indirect taxes eventually causes inelasticity to turn into elasticity: in time, the market shrinks as taxes go up. The current account deficit could balloon yet again as remittances, the great, unexplained boon the past few years, stagnate, putting pressure on the exchange rate and making the days of the 100-rupee dollar a distinct possibility.

Must all this necessarily happen? No. Is it politically inevitable? Yes.

The challenges may be grim, but they are not insurmountable — yet. What is terrifying some people in Islamabad, however, is the attitude of the present government. Like first-class passengers demanding caviar on a sinking Titanic, the federal government seems supremely unaware of the storm that is slowly engulfing it.

Meetings are held on critical economic matters, but decisions are deferred. Ministers prefer to rearrange papers on their desks, if they bother to come in to office at all, rather than study how to push through reforms. At the very top … well, never mind. A presidential helicopter touching down at a chateau in the land of Marie Antoinette said it all.

How can an elected government be so catastrophically, diabolically, maniacally bad? It doesn’t seem to make any sense. The panic alarms are ringing furiously across the country, warning the PPP of an electoral wipe-out the next time round. Wouldn’t surviving to plunder this land some more be an incentive? Why court your own doom?

The answer, alas, seems to lie in a game somewhere else. Zardari and his ribald bunch of misfits appear to be making the ultimate high-stakes bet: that if Pakistan stands at the precipice, arms aloft, seemingly ready to embrace her fate, western hands will claw her back to safety.

It goes something like this. The West will generally not let Pakistan fail because the consequences of failure here are too serious for the region and the world at large. The West will specifically not let the present government fail because it represents the best coalition for claiming public support in the fight against militancy. Combine the general with the specific, and voila! You have an unbeatable hand.

Welcome to Bailout City. Why do the heavy lifting when others will do it for you?

Except, not really. One, there’s little to no appetite in the US to bail out a profligate, corrupt government unwilling to get serious about governance. The Americans have a back-up plan: the IMF. That’s where they send the serial offenders and chronic delinquents for the one-size-fits-all treatment.

Since we are already in the embrace of the IMF, round two will call for tougher measures. The first time they forced us to slash subsidies; the second time they’ll take the scalpel to the public sector.

Public sector enterprises (PSEs) lost Rs250bn last year. Outsiders like the International Monetary Fund (IMF) don’t know how to stop that haemorrhaging in a sophisticated way; they will force the obvious: slash salary expenditures. Which means layoffs. A more sophisticated negotiating team from the Pakistani side may be able to minimise the cutbacks, but if sophistication was a trademark of this government, we wouldn’t be in the mess we are in.

Note, though, that the first round of the IMF package hasn’t saved Pakistan, it has just made a bigger mess of things. Electricity prices have been jacked up by 70 per cent in some instances, and yet the sector is on the verge of collapse

It doesn’t take a PhD in economics to figure out why: inefficiencies — a nice word for incompetence, corruption, mismanagement, malfeasance, misfeasance, general thuggery and an unwillingness to play by the rules — aren’t fixed by throwing more money at a problem.

Even if you were to double the price of electricity, the sector wouldn’t become liquid. In fact, it would probably veer towards insolvency, with customers refusing to pay their bills altogether, the fundamental reason for the circular-debt crisis today.

Similarly, slashing the headcount at PSEs will not stanch the losses there. The Railways loses money not because it has too many employees but because it is operating in a structurally flawed market. If you support road carriage at a policy level, as has been the case for decades since the creation of the National Logistics Cell (NLC), there’s little a railways can do — the market will gravitate towards the cheaper option, in this case cheaper because of a deliberate, dubious policy.

(As an aside, the civil-military imbalance has skewed the economy in ways not many understand or even recognise, NLC being a major example.)

In short, the IMF sausage maker is really a meat grinder: what comes out is often messier than what goes in. And a second bailout — post-floods, a virtual certainty — is often worse than the first.

So Zardari & co are really making a losing bet: the financial ‘rescue’ from the West may be worse than the original problem. Then again, that may not seem like such a big deal when you have a chateau — or are selling it or renovating it or whatever he was doing out there. But the rest of us don’t have a chateau to escape to and so we must worry about things like a collapsing economy.

Which brings us to Zardari’s second problem: survivability. In a high-stakes game of bluff, you need to be sure the other side doesn’t have options. But that’s never the case in Pakistan. There are always options.

1999-2002 wasn’t very long ago. Many remember it fondly, for its attention and commitment to reform. Why green-light another bailout for a tried-and-failed lot that will just kick the reform ball down the road again? Why not just fold and walk away from a swaggering Zardari?

Zardari may be too arrogant to care about the media response here, but the scorn heaped on him by the western media will have send chills down the spines of his smarter (!) advisers.

They know the West’s demand for reform is greater than its love for democracy here.

Link: http://www.dawn.com/wps/wcm/connect/...apse-380-hh-19 ]]> Current Affairs Asad http://pkforum.com/vb/threads/11761-Economic-collapse